XML 13 R2.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2020
Dec. 31, 2019
Current assets    
Cash and cash equivalents $ 461,956 $ 135,089
Marketable securities 93,422 266,740
Prepaid expenses and other current assets 10,828 7,488
Total current assets 566,206 409,317
Property and equipment, net 5,717 5,425
Operating lease right-of-use assets 11,394 10,303
Other assets 861 1,559
Total assets 584,178 426,604
Current liabilities    
Accounts payable 865 956
Accrued research and development expenses 12,239 19,258
Accrued expenses and other current liabilities 19,503 16,709
Total current liabilities 32,607 36,923
Long-term convertible senior notes 142,158 0
Long-term debt 28,665 28,459
Operating lease liabilities - long-term 8,647 8,737
Total liabilities 212,077 74,119
Commitments and contingencies
Stockholders' equity    
Common stock, $0.0001 par value; 700,000,000 shares authorized as of September 30, 2020 and December 31, 2019; 75,907,527 shares issued and 72,475,912 shares outstanding as of September 30, 2020, and 66,284,003 shares issued and 61,635,477 shares outstanding as of December 31, 2019 8 7
Additional paid-in capital 884,677 686,390
Accumulated deficit (512,926) (334,170)
Accumulated other comprehensive income 342 258
Total stockholders' equity 372,101 352,485
Total liabilities and stockholders' equity $ 584,178 $ 426,604